Proteomic profiling of lipid rafts in a human breast cancer model of tumorigenic progression

Clinical and Experimental Metastasis

Volumn 28, Issue 6, 2011, Pages 529-540

  Caruso, Joseph A ^a   Stemmer, Paul M ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Biomarkers; Breast cancer; Caveolin 1; Filamin A; iTRAQ; Keratin; Lipid rafts; Mass spectrometry; MCF10A; Vimentin

Indexed keywords

BIOLOGICAL MARKER; CAVEOLIN 1; CYTOKERATIN 17; CYTOKERATIN 5; CYTOKERATIN 6; FILAMIN A; GLYCOSYLPHOSPHATIDYLINOSITOL; GUANINE NUCLEOTIDE BINDING PROTEIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER MODEL; CELL LINEAGE; CELL PROLIFERATION; CELL TRANSFORMATION; FEMALE; HUMAN; HUMAN CELL; INTERMEDIATE FILAMENT; LIPID RAFT; METASTASIS; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRECANCER; PROTEIN CONTENT; PROTEIN INTERACTION; PROTEOMICS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

BREAST NEOPLASMS; CAVEOLIN 1; CONTRACTILE PROTEINS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; KERATINS; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; MODELS, BIOLOGICAL; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 79960921962     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-011-9389-5     Document Type: Article

References (58)

1. MF Hanzal-Bayer JF Hancock 2007 Lipid rafts and membrane traffic FEBS Lett 581 2098 2104 17382322 10.1016/j.febslet.2007.03.019 1:CAS:528: DC%2BD2sXlt1Chsrc%3D (Pubitemid 46709907)
2. D Lingwood K Simons 2010 Lipid rafts as a membrane-organizing principle Science 327 46 50 20044567 10.1126/science.1174621 1:CAS:528:DC%2BD1MXhs1WksrfJ
3. SK Patra 2008 Dissecting lipid raft facilitated cell signaling pathways in cancer Biochim Biophys Acta 1785 182 206 18166162 1:CAS:528: DC%2BD1cXkvFWlur8%3D
4. P Lajoie JG Goetz JW Dennis, et al. 2009 Lattices, rafts and scaffolds: domain regulation of receptor signaling at the plasma membrane J Cell Biol 185 3 381 385 19398762 10.1083/jcb.200811059 1:CAS:528:DC%2BD1MXlvFSrur8%3D
5. HD Soule TM Maloney SR Wolman, et al. 1990 Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10 Cancer Res 50 6075 6086 1975513 1:CAS:528:DyaK3MXktFSq (Pubitemid 20331424)
6. J Russo L Tait IH Russo 1991 Morphological expression of cell transformation induced c-Ha-ras oncogene in human breast epithelial cells J Cell Sci 99 453 463 1885681 (Pubitemid 21925032)
7. PJ Dawson SR Wolman L Tait, et al. 1996 MCF10AT: a model for the evolution of cancer from proliferative breast disease Am J Pathol 148 1 313 319 8546221 1:STN:280:DyaK287jtlWjtw%3D%3D
8. SJ Santner PJ Dawson L Tait, et al. 2001 Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells Breast Cancer Res Treat 65 101 110 11261825 10.1023/A:1006461422273 1:STN:280: DC%2BD3M7mtVWitA%3D%3D (Pubitemid 32193613)
9. RS Ostrom X Liu 2007 Detergent and detergent-free methods to define lipid rafts and cavaeolae Methods Mol Biol 400 459 468 17951752 10.1007/978-1-59745- 519-0-30 1:CAS:528:DC%2BD2sXht1SjurzL (Pubitemid 350183707)
10. TJ Griffin H Xie S Bandhakavi, et al. 2007 iTRAQ reagent-based quantitative proteomic analysis on a linear ion trap mass spectrometer J Proteome Res 6 4200 4209 17902639 10.1021/pr070291b 1:CAS:528:DC%2BD2sXhtFSjt7fI (Pubitemid 350158498)
11. J Feng H Xie DL Meany, et al. 2008 Quantitative proteomic profiling of muscle type-dependent and age-dependent protein carbonylation in rat skeletal muscle mitochondria J Gerontol 63A 11 1137 1152 1:CAS:528:DC%2BD1MXhslWhs7k%3D (Pubitemid 352772034)
12. JA Caruso JJ Reiners Jr 2006 Proteolysis of HIP during apoptosis occurs within a region similar to the BID loop Apoptosis 11 11 1877 1885 17013759 10.1007/s10495-006-0083-z 1:CAS:528:DC%2BD28XhtFKmtr3I (Pubitemid 44691572)
13. JA Caruso PA Mathieu JJ Reiners Jr 2005 Sphingomyelins suppress the targeted disruption of lysosomes/endosomes by the photosensitizer NPe6 during photodynamic therapy Biochem J 392 2 325 334 15943580 10.1042/BJ20050313 1:CAS:528:DC%2BD2MXht1CrtLbN (Pubitemid 41796521)
14. Y Feng CA Walsh 2004 The many faces of filamin: a versatile molecular scaffold for cell motility and signalling Nat Cell Biol 6 1034 1038 15516996 10.1038/ncb1104-1034 1:CAS:528:DC%2BD2cXptFent7w%3D (Pubitemid 39468003)
15. O Alper WG Stetler-Stevenson LN Harris, et al. 2009 Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma Cancer Sci 100 9 1748 1756 19594548 10.1111/j.1349-7006.2009.01244.x 1:CAS:528:DC%2BD1MXhtFOhurnK
16. RG Parton 1994 Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae J Histochem Cytochem 42 2 155 166 8288861 10.1177/42.2.8288861 1:CAS:528:DyaK2cXhtlSgurs%3D (Pubitemid 24042232)
17. S Mishra SR Ande LG Grégoire Nyomba 2010 The role of prohibitin in cell signaling FEBS J 277 19 3937 3946 20840588 10.1111/j.1742-4658.2010.07809. x 1:CAS:528:DC%2BC3cXht1eisbvI
18. S Staubach H Razawi FG Hanisch 2009 Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7 Proteomics 9 10 2820 2835 19415654 10.1002/pmic.200800793 1:CAS:528: DC%2BD1MXmtlOmtLw%3D
19. KB Kim JW Lee CS Lee, et al. 2006 Oxidation-reduction respiratory chains and ATP synthase complex are localized in detergent-resistant lipid rafts Proteomics 6 8 2444 2453 16526083 10.1002/pmic.200500574 1:CAS:528: DC%2BD28XkslCgsLk%3D
20. J Ponce D Brea M Carrascal, et al. 2010 The effect of simvastatin on the proteome of detergent-resistant membrane domains: decreases of specific proteins previously related to cytoskeletal regulation, calcium homeostasis and cell fate Proteomics 10 10 1954 1965 20217863 10.1002/pmic.200900055 1:CAS:528:DC%2BC3cXmtVylurg%3D
21. SR Ande S Mishra 2010 Palmitoylation of prohibitin at cysteine 69 facilitates its membrane translocation and interaction with Eps 15 homology domain protein 2 (EHD2) Biochem Cell Biol 88 3 553 558 20555396 10.1139/O09-177 1:CAS:528:DC%2BC3cXmtlKks7g%3D
22. PJ Coates R Nenutil RA McGregor, et al. 2001 Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence Exp Cell Res 265 2 262 273 11302691 10.1006/excr.2001.5166 1:CAS:528: DC%2BD3MXis1ersbc%3D (Pubitemid 32980214)
23. AL Stratford K Reipas C Maxwell, et al. 2010 Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer Expert Rev Mol Med 12 e22 20653987 10.1017/S1462399410001535
24. RH Alvarez V Valero GN Hortobagyi 2010 Emerging targeted therapies for breast cancer J Clin Oncol 28 20 3366 3379 20530283 10.1200/JCO.2009.25.4011 1:CAS:528:DC%2BC3cXhtVajurvF
25. F Baruthio M Quadroni C Ruegg, et al. 2008 Proteomic analysis of membrane rafts of melanoma cells identifies protein patterns characteristic of the tumor progression stage Proteomics 8 4733 4747 18942674 10.1002/pmic.200800169 1:CAS:528:DC%2BD1cXhsV2js7rP
26. HH Patel F Murray PA Insel 2008 G-protein-couples receptor-signaling components in membrane raft and caveolae microdomains Handb Exp Pharmacol 186 167 184 18491052 10.1007/978-3-540-72843-6-7 1:CAS:528:DC%2BD1MXhs1Sru70%3D
27. FJ Sharom MT Lehto 2002 Glycosylphosphatidylinositol-anchored proteins: structure, function, and cleavage by phosphatidylinositol-specific phospholipase C Biochem Cell Biol 80 535 549 12440695 10.1139/o02-146 1:CAS:528: DC%2BD38Xos1aisrY%3D (Pubitemid 36124815)
28. KJ Mann MR Hepworth NS Raikwar 2004 Effect of glycosylphosphatidylinositol (GPI)-phospholipase D overexpression on GPI metabolism Biochem J 378 641 648 14611645 10.1042/BJ20031326 1:CAS:528:DC%2BD2cXisVajt70%3D (Pubitemid 38367254)
29. X He MJ Hannocks I Hampson, et al. 2002 GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy Clin Exp Metastasis 9 4 291 299 10.1023/A:1015545407700 (Pubitemid 34606754)
30. C Birchmeier W Birchmeier B Brand-Saberi 1996 Epithelial mesenchymal transitions in cancer progression Acta Anat 156 217 226 9124038 10.1159/000147848 1:STN:280:DyaK2s7otlOgtA%3D%3D (Pubitemid 27072577)
31. MI Kokkinos R Wafai MK Wong, et al. 2007 Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo Cells Tissues Organs 185 1-3 191 203 17587825 10.1159/000101320 1:CAS:528:DC%2BD2sXmvFSnu70%3D (Pubitemid 46957486)
32. PA Thomas DA Kirschmann JR Cerhan 1999 Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients Clin Cancer Res 5 2698 2703 10537332 1:CAS:528: DyaK1MXntlGltLg%3D (Pubitemid 29493942)
33. MH Chen GW Yip GM Tse, et al. 2008 Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters Mod Pathol 21 1183 1191 18536655 10.1038/modpathol.2008.90 1:CAS:528:DC%2BD1cXhtFGhs7fO
34. DJ Dabbs M Chivukula G Carter 2006 Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile Mod Pathol 19 1506 1511 16941011 10.1038/modpathol.3800538 1:CAS:528:DC%2BD28XhtFShtrnM (Pubitemid 43276987)
35. N Kuroda M Ohara K Inoue, et al. 2009 The majority of triple-negative breast cancer may correspond to basal-like carcinoma, but triple-negative breast cancer in not identical to basal-like carcinoma Med Mol Morphol 42 128 131 19536621 10.1007/s00795-008-0428-5 1:CAS:528:DC%2BD1MXntlOgsbo%3D
36. M van de Rijn CM Perou R Tibshirani, et al. 2002 Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome Am J Pathol 161 6 1991 1996 12466114 10.1016/S0002-9440(10)64476-8 (Pubitemid 35434844)
37. MJC Hendrix EA Seftor REB Seftor, et al. 1997 Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior Am J Pathol 150 483 495 9033265 1:CAS:528:DyaK2sXhtlSntL0%3D (Pubitemid 27073779)
38. L McInroy A Maatta 2007 Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion Biochem Biophys Res Commun 360 109 114 17585878 10.1016/j.bbrc.2007.06.036 1:CAS:528:DC%2BD2sXntFamsbw%3D (Pubitemid 46990330)
39. LY Choong S Lim PK Chong, et al. 2010 Proteome-wide profiling of the MCF10AT breast cancer progression model PLoS One 5 6 e11030 20543960 10.1371/journal.pone.0011030
40. SW Lee CL Reimer P Oh, et al. 1998 Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells Oncogene 16 1391 1397 9525738 10.1038/sj.onc.1201661 1:CAS:528:DyaK1cXit1Cjtrw%3D (Pubitemid 28151846)
41. AJ Koleske D Baltimore MP Lisanti 1995 Reduction of caveolin and caveolae in oncogenically transformed cells Proc Natl Acad Sci USA 92 1381 1385 7877987 10.1073/pnas.92.5.1381 1:CAS:528:DyaK2MXktFWkt74%3D
42. I Mercier MC Casimiro C Wang, et al. 2008 Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: implications for the response to hormonal therapy Cancer Biol Ther 7 1212 1225 18458534 10.4161/cbt.7.8.6220 1:CAS:528: DC%2BD1cXht1GqsrzF
43. P Wua X Wang F Lib, et al. 2008 Growth suppression of MCF-7 cancer cell-derived xenografts in nude mice by caveolin-1 Biochem Biophys Res Commun 376 1 215 220 10.1016/j.bbrc.2008.08.146
44. G Fiucci D Ravid R Reich, et al. 2002 Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells Oncogene 21 15 2365 2375 11948420 10.1038/sj.onc.1205300 1:CAS:528:DC%2BD38XivFykurY%3D (Pubitemid 34413560)
45. TM Williams F Medina I Badano, et al. 2004 Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion J Biol Chem 279 49 51630 51646 15355971 10.1074/jbc.M409214200 1:CAS:528:DC%2BD2cXhtVaqs7nJ (Pubitemid 40017914)
46. G Perrone V Altomare M Zagami, et al. 2009 Caveolin-1 expression in human breast lobular cancer progression Mod Pathol 22 71 78 18836420 10.1038/modpathol.2008.154 1:CAS:528:DC%2BD1MXht1ejuw%3D%3D
47. B Weigelt FC Geyer R Natrajan MA Lopez-Garcia AS Ahmad K Savage B Kreike JS Reis-Filho 2010 The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type J Pathol 220 1 45 57 19877120 10.1002/path.2629 1:CAS:528:DC%2BC3cXpvFOisg%3D%3D
48. EK Sloan DR Ciocca N Pouliot, et al. 2009 Stromal cell expression of caveolin-1 predicts outcome in breast cancer Am J Pathol 174 6 2035 2043 19411449 10.2353/ajpath.2009.080924 1:CAS:528:DC%2BD1MXmvFOquro%3D
49. AK Witkiewicz A Dasgupta KH Nguyen, et al. 2009 Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer Cancer Biol Ther 8 11 1071 1079 19502809 10.4161/cbt.8.11.8874 1:CAS:528:DC%2BD1MXhtVehsbbE
50. AK Witkiewicz A Dasgupta S Sammons, et al. 2010 Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers Cancer Biol Ther 10 2 135 143 20431349 10.4161/cbt.10.2.11983
51. G Yang LD Truong TL Timme, et al. 1998 Elevated expression of caveolin is associated with prostate and breast cancer Clin Cancer Res 4 8 1873 1880 9717814 1:CAS:528:DyaK1cXls1Ghurg%3D (Pubitemid 28369170)
52. SM Pinilla E Honrado D Hardisson, et al. 2006 Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer Breast Cancer Res Treat 99 1 85 90 16541313 10.1007/s10549-006-9184-1 1:CAS:528:DC%2BD28XnslShsbo%3D (Pubitemid 44168607)
53. K Savage MB Lambros D Robertson, et al. 2007 Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis Clin Cancer Res 13 1 90 101 17200343 10.1158/1078-0432.CCR-06-1371 1:CAS:528:DC%2BD2sXotlel (Pubitemid 46121857)
54. SE Elsheikh AR Green EA Rakha, et al. 2008 Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype Br J Cancer 99 2 327 334 18612310 10.1038/sj.bjc.6604463 1:CAS:528: DC%2BD1cXosFWntrY%3D
55. A Mammoto S Huang DE Ingber 2007 Filamin links cell shape and cytoskeletal structure to Rho regulation by controlling accumulation of p190RhoGAP in lipid rafts J Cell Sci 120 456 467 17227794 10.1242/jcs.03353 1:CAS:528:DC%2BD2sXjtlSku78%3D (Pubitemid 46332509)
56. R Tavano RL Contento SJ Baranda, et al. 2006 CD28 interaction with filamin-A controls lipid raft accumulation at the T-cell immunological synapse Nat Cell Biol 8 11 1270 1276 17060905 10.1038/ncb1492 1:CAS:528: DC%2BD28XhtFCqu7jF (Pubitemid 44660592)
57. D Ravid D Chuderland L Landsman, et al. 2008 Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration Exp Cell Res 314 15 2762 2773 18598695 10.1016/j.yexcr.2008.06.004 1:CAS:528: DC%2BD1cXhtVKnu7nM
58. Y Xu TA Bismar J Su, et al. 2010 Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion J Exp Med 207 11 2421 2437 20937704 10.1084/jem.20100433 1:CAS:528:DC%2BC3cXhsVSktLzL